1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001.

Saved in:
Bibliographic Details
Title: 1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001.
Authors: Fujimoto, N.1 (AUTHOR), Kozuki, T.2 (AUTHOR), Aoe, K.3 (AUTHOR), Miyamoto, Y.4 (AUTHOR), Wada, S.4 (AUTHOR), Harada, D.2 (AUTHOR), Yoshida, M.5 (AUTHOR), Sakurai, J.5 (AUTHOR), Hotta, K.5 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1077-S1077. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.1441